TLR2 and TLR4 mRNA expression levels in liver transplant patients with acute rejection

Zahra Keshavarz1, Neda Zareei2, Afsoon Afshari3

  • 1Department of Biology, Jahrom Branch, Islamic Azad University, Jahrom, Iran.

Immunobiology
|June 30, 2021
PubMed

Insights

Toll-like receptors (TLRs) play a key role in transplant rejection. This study found that TLR2 and TLR4 expression levels can help identify acute rejection (AR) after liver transplantation, suggesting their potential as biomarkers.

Area of Science:

  • Immunology
  • Transplantation Science
  • Molecular Biology

Background:

  • Toll-like receptors (TLRs) are crucial in innate immunity and cytokine production, influencing transplant outcomes.
  • Activation of TLRs can lead to graft rejection, highlighting their significance in transplantation.

Purpose of the Study:

  • To assess the expression levels of Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4) in acute rejection (AR) post-liver transplantation.
  • To determine the correlation of TLR expression between the 1st and 7th day post-transplantation.
  • To evaluate the potential of TLR2 and TLR4 as biomarkers for AR.

Main Methods:

  • Real-time PCR was used to measure TLR2 and TLR4 mRNA expression in patients with AR (n=50), without AR (n=50), and controls.
  • Expression levels were analyzed on the 1st and 7th day post-transplantation.
  • Receiver Operating Characteristic (ROC) curve analysis was performed to determine cut-off values for TLR expression.

Main Results:

  • TLR4 mRNA was significantly upregulated in AR patients on day 1 but downregulated in non-AR patients compared to controls.
  • Both TLR2 and TLR4 expression increased in the AR group compared to the non-AR group on day 7.
  • TLR2 expression showed a positive correlation between day 1 and day 7 in both AR and non-AR groups.
  • ROC analysis identified a TLR2 cut-off value of 0.98, distinguishing AR from non-AR with 71.05% sensitivity and 63.27% specificity.

Conclusions:

  • TLR2 and TLR4 expression are significantly associated with acute rejection following liver transplantation.
  • These TLRs demonstrate potential as predictive biomarkers for AR.
  • Understanding TLR involvement can guide the development of targeted immunotherapeutic strategies.

Related Concept Videos